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Abstract:
Although participation in health policy-making is a popular topic in the literature and a
stated priority of the United Nations, very little research has been published examining the full
spectrum of participation by people who use drugs (PWUD) at the UN level. This study aims to
describe and evaluate this participation through a combination of a literature review that looks at
academic sources, UN publications, and publications by organizations of PWUD, and a series of
interviews with representatives of organizations of PWUD who have participated in UN level
policy-making.
Data collected demonstrates that there is no comprehensive system for the participation
of PWUD in policy-making at the UN, although they are more integrated into spaces concerned
with HIV/AIDS than any other, and that people who use drugs face a variety of logistical,
discursive, and structural barriers to meaningful participation. However, organizations led by
PWUD have created inroads and developed strategies to participate both as activists and
technical advisors at the UN, including public appeals, event attendance, and leveraging of UN
contacts. Significant structural changes are needed at the UN to fully remove barriers to
participation by PWUD.
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Introduction
United Nations bodies including the UN Office on Drugs and Crime (UNODC), the
World Health Organization (WHO), and the Joint United Nations Programme on HIV/AIDS
(UNAIDS) regularly make policies and recommendations which affect the lives of people who
use drugs across the globe. However, very little research has examined critically how people who
use drugs participate, or are blocked from participating, in the creation of these policies and
reccommendations. Participation in policy-making, and participation especially of minority
groups, has been widely researched, but people who use drugs have been largely left out of the
conversation.
This study aims not only to examine the “involvement” of people who use drugs in
policy-making –– in other words, whether or not people who use drugs are present in
policy-making spaces –– but also the meaningful participation of people who use drugs.
“Meaningful participation” is a term designed to capture the idea of participation that goes
beyond symbolic presence, in which the full spectrum of people who use drugs are represented,
people who use drugs are involved in every space where drug-related policy is made, people who
use drugs are heard and the expertise brought is taken seriously and has the potential to affect
change, and people who use drugs are credited for their contributions. This study is exclusively
concerned with direct participation, not secondary participation as it might occur through the
filter of people or bodies which do not directly represent organizations of people who use drugs.
The goal of this study is to describe as fully as possible the current state of participation
by organizations of people who use drugs in UN-level policy-making. Emphasis is placed on
identifying both the current barriers to meaningful participation and the strategies used by
organizations of people who use drugs to respond to these barriers. The aim is to find both the

2
pathways for participation currently available and recognize the roadblocks which limit
participation on the way. This analysis relies heavily on contributions from representatives of
organizations of people who use drugs.
The process of policy-making and meaningful participation of people who use drugs
therein is important to the field of public health. The process of policy-making impacts both the
policy that gets made and the perceived legitimacy of said policy. It is impossible to create
legitimate and effective health policy without consulting thoroughly the population which that
policy affects. And, as stated in the oft repeated phrase, “all policy is health policy,” one cannot
separate policies made about the legal status of certain drugs from policies surrounding harm
reduction, treatment, and the overall health and wellbeing of people who use drugs.
After a brief note on language and an overview of methodology, this paper consists of a
literature review, which covers broad areas such as current theories of public participation in
health policy, mobilization by people who use drugs and the role people who use drugs play in
their own health, and the current state of participation by people who use drugs at the United
Nations. Then interviews are analyzed for key themes, barriers to participation, and case studies
of participation of people who use drugs at the United Nations. Each section is designed to build
on the last and create a map of the current state of participation by organizations of people who
use drugs at the United Nations.

A note on language
Throughout the paper, the term “people who use drugs,” hereafter abbreviated as PWUD,
will be used. Substance use has a long history of stigmatizing language, in and out of the medical
community. Many terms surrounding drugs and drug use have the potential to cause harm and
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perpetuate stigma: a report from the global commission on drug policy acknowledges the adverse
effect of terms including “addict,” “substance/drug abuser,” and “clean,” as used in reference to
persons in recovery.1 Even more seemingly neutral language, such as “drug user” can have a
stigmatizing impact by centering a behavior in the conversation instead of human dignity. For
this reason, modern scholars and organizations of PWUD are promoting the use of “people-first”
language, an idea arising from disability scholarship, which respects the individuals concerned
by centering personhood and addressing traits, behaviors, or medical conditions second.2 While
some scholarship will use people-first language which is more specific than PWUD, such as
people who inject drugs, people who use opioids, or people with a substance use disorder, this
piece is not interested in one specific mode of delivery, type of drug, or biomedical condition.
Rather, the object of study is organizations which explicitly identify as being led by and
representing PWUD.

Methodology and Research Ethics
This research was developed through the combination of a literature review and
qualitative interviews with representatives of organizations of PWUD who have participated in
the creation of international policy. Ultimately the research is qualitative, descriptive and critical,
and aims to both identify and critique the current state of affairs in the field.
Literature review consisted of a broad search of available English literature in a set of
thematic areas including participation in health policy, mobilization and organization by PWUD,
1

Global Commission on Drug Policy. The world drug perception problem-countering prejudices about people who
use drugs: 2017 report. Jan 2018.
www.globalcommissionondrugs.org/wp-content/uploads/2018/01/GCDP-Report-2017_Perceptions-ENGLISH.pdf.
2
Broyles, Lauren M., Ingrid A. Binswanger, Jennifer A. Jenkins, Deborah S. Finnell, Babalola Faseru, Alan
Cavaiola, Marianne Pugatch, and Adam J. Gordon. "Confronting Inadvertent Stigma and Pejorative Language in
Addiction Scholarship: A Recognition and Response." Substance Abuse 35, no. 3 (07, 2014): 217-221.
doi:http://dx.doi.org/10.1080/08897077.2014.930372.
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and policy participation by PWUD at the UN. In addition, key UN documents that cover or
prioritize the participation of people who use drugs in policy making were highlighted. Key
publications by a research team at UNSW formed the backbone of the literature review and
contributed to the development of other thematic areas and the research overall. These
publications represent some of the only available academic literature on the participation of
PWUD at the UN. Therefore, aspects of the literature search relied upon publications by
organizations of PWUD, specifically INPUD, an organization which publishes opinions,
scientific literature, and reviews of its own activities.
Due in part to the limited state of the literature at present, this research relies heavily on
data generated through the qualitative interview process. Three people were interviewed:
Executive Director of the International Network of People Who Use Drugs Judy Chang,
President of the Board of the Canadian Association of People Who Use Drugs and Chair of the
Toronto Drug Users Union Frank Crichlow, and a third participant who attended represented a
youth organization and chose to remain anonymous. Each of these participants participated in
some capacity at the UN as a representative of an organization led by PWUD, and two have
leadership roles in their organizations. It was particularly important to contact representatives of
INPUD and associated regional networks because of the leadership role this organization has
taken in the international sphere. Interview participants were contacted through either emails
available on university or organizational websites or through referals after making inquiries via
social media messaging. All interviews were semi-structured, including both pre-written
questions shared with the interviewees before the interview and elements of spontaneous
conversational interviewing. The goal of the interviews was to capture information about
processes of being involved as representatives of organizations of PWUD at the UN and to
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provide a forum for interview participants to share opinions and expertise. All interview
participants were given the option to remain anonymous, one of whom accepted. In addition,
interview participants had the opportunity to review and approve the comments included in the
final version of this paper.
A few ethical considerations were necessary to consider in the collection and analysis of
interview data. First, this research concerned “drugs” as a broad topic, an issue which is
potentially sensitive. However, I engaged primarily with advocates for PWUD about their
advocacy, around which they have built their professional careers and which they speak about
professionally on a regular basis. In addition, participants were not required to answer any
question for any reason, although none of the questions were ultimately refused. Second, this
research acknowledges the regular cultural delegitimization of the expertise of PWUD and the
failure of many bodies to acknowledge that expertise, even when it is used. Thus I must
acknowledge here that this work was driven and informed by representatives of organizations of
people who use drugs, including Judy Chang of INPUD and Frank Crichlow of CAPUD, and
that I hope that this research might play a role in furthering the participation of PWUD in
policy-making and highlighting their voices. Third, Frank Crichlow pointed out to me that the
typical language of academia around drug use, in addition to being potentially harmful, is not the
language used by PWUD, making it inaccessible to the population about whom it is written. I’d
like to thank him here for his insight and acknowledge that throughout this research I will
attempt to use accessible language which is not overly “distant” or “academic” in nature,
acknowledging my positionality as a university student and researcher which strongly affects my
perspective in the context of this conversation.
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Finally, there were certain limitations to the development of this research methodology.
Initially, I scheduled or attempted to schedule interviews with researchers from academic
institutions and doctors who participated in some of these policy-making processes, but who
were not from organizations of people who use drugs. A combination of time constraints and
unanticipated personal events in the lives of the participants led to these perspectives not being
included in research. Two interviews with experienced researchers in the field were also
cancelled due to unanticipated personal events. In addition, I initially aimed to incorporate a
quantitative element which examined whether there was participation by organizations of PWUD
in policy-making processes at UNAIDS and the WHO. However, due primarily to the way that
events like meetings of the UNAIDS Program Coordinating Board are documented, the
placement of organizations of PWUD only in the recesses of documentation, and limited
personal resources, this particular mode of analysis could not be included at this time. Instead,
research was oriented entirely around the perspectives and experiences of the representatives
interviewed.

Literature Review:
Theory of Public Participation in Health Policy
In theory, public participation in health-system decision making is designed to respect the
doctrine of informed consent in the public, create greater responsiveness, increase financial
accountability, and produce more effective programs, born of population consensus and
priorities.3 Public participation in the formulation of health regulation and policy is associated
with greater responsiveness, better services, and healthier populations. However, participation
3

Frankish, James C, Brenda Kwan, Pamela A Ratner, Joan Wharf Higgins, Craig Larsen,
Challenges of citizen participation in regional health authorities, Social Science & Medicine, Volume 54, Issue 10,
2002, Pages 1471-1480, ISSN 0277-9536, https://doi.org/10.1016/S0277-9536(01)00135-6.
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also has the potential to exacerbate health inequities if minority populations are not included
meaningfully, as vocal majorities may steer health policy to meet primarily the majority's
demands.4
Much of the literature on participation advocates for theoretical reasons for participation,
such as the belief that people have the right to participate in the planning, implementation, and
evaluation of their health systems, the claim that health needs and services should be better
matched, and that participation fosters community empowerment through the creation of a sense
of contribution. Reasons for building more participation into policy-making can also be practical,
focusing on untapped community resources mobilized through parrticipation, more inputs and
comprehensive solutions through community engagement, and the belief that participation may
lead to greater cost-efficacy and efficiency. Citizen participation in the planning of health
services may also result in greater awareness of health problems and use of said services. Of
course, scholars also argue against public participation on account of the potential for greater
expertise by health authorities, potential negative impacts on quality of care, the lower
accountability members of the public may have in comparison to professionals, and the potential
high costs and inefficiencies of participation.5 However, citizen participation has absolutely
become a “buzzword” throughout the global health field.
Public participation in health systems governance is a widely accepted idea within the
UN system. For example in 2005 the Ninth Futures Forum produced a comprehensive overview
of the role of public participation in health systems decision-making, producing a conceptual
framework, reviewing European examples, and trying to guide countries in the process of

4

de Freitas, Cláudia and Graham Martin. "Inclusive Public Participation in Health: Policy, Practice and Theoretical
Contributions to Promote the Involvement of Marginalised Groups in Healthcare." Social Science & Medicine 135,
(06, 2015): 31-39. doi:http://dx.doi.org/10.1016/j.socscimed.2015.04.019.
5
Frankish et al, “Challenges of citizen participation in regional health authorities” 1471-1480.
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building a participation-based policy-making healthcare system. The World Health Organization
advocates for participation as “a goal in its own right” and “a main requirement of
policy-making.”6 Despite the wide acceptance of public participation as fundamental to
policy-making, PWUD are often under-represented in deliberations surrounding their health and
health services.

The key role of PWUD in harm reduction
Across much of the world, PWUD are systemically stigmatized and treated, in one way
or another, as a form of social ill. However, within the field of harm reduction, scholars and
stakeholders have long accepted that PWUD are the most important potential health-promoters
within communities of PWUD. PWUD were involved in the initial development and delivery of
harm reduction strategies now considered essential to any effective health promotion for PWUD.
In high income countries, peer-organizing has had a positive impact on service reach,
accessibility, and quality. In low and middle income countries, peer involvement in harm
reduction services has resulted in reduced HIV incidence and prevalence, greater service access,
acceptability and quality, altered risk behaviors and reduced stigma and discrimination.7 Highly
effective life-saving harm reduction strategies, such as peer-administered naloxone, "treat the
social contexts of drug use as crucial resources for intervention."8 Thus it is important to
acknowledge that the participation of PWUD in their own health and the health of their
communities is an essential tool for effective health promotion. Finally, if PWUD are essential to
6

Jakubowski, Elke, Graham Lister, Regina Skavron, and World Health Organization. "Ninth Futures Forum on
health systems governance and public participation: Amsterdam, The Netherlands, 10-11 October 2005." (2006).
7
Chang, Judy, Shaun Shelly, Machteld Busz, Claudia Stoicescu, Rachman Iryawan Arif, Dinara Madybaeva, Yuri de
Boer, and Andy Guise. "Peer Driven Or Driven Peers? A Rapid Review of Peer Involvement of People Who use
Drugs in HIV and Harm Reduction Services in Low- and Middle-Income Countries." Harm Reduction Journal 18,
(2021): 1-13. doi:http://dx.doi.org/10.1186/s12954-021-00461-z.
8
Faulkner-Gurstein, Rachel. (2017). The social logic of naloxone: Peer administration, harm reduction, and the
transformation of social policy. Social Science & Medicine. 180. 10.1016/j.socscimed.2017.03.013.

9
the organization of their own health and health promotion, it becomes logically inconsistant that
PWUD are not systematically included in the development of those health systems at every level.

Community Organizing by PWUD
Organizations of PWUD have existed for decades. In the 1970's the "Junkie Bond" was
developed in the Netherlands to lobby about treatment and misrepresentation of PWUD. In 1973
the Committee of Concerned Methadone Patients and Friends Inc. was formed in the United
States to advocate for people in drug treatment programs. Since the HIV/AIDS epidemic, PWUD
formed organizations in many countries, and such organizations have existed on every continent
since 2008.9 In 2012, most organizations of PWUD, in this case limited to organizations led by
and advocating for users of “hard” drugs, and not including organizations of cannabis-users or
people who used to use drugs, were located in Europe, although such organizations were present
in at least forty countries throughout the world. These organizations advocate not only for health
care and information but also for the rights of PWUD, seeking objectives such as
decriminalization.They include local, national, and international organizations. Organizations of
PWUD offer many opportunities, but also face challenges. One major challenge to the ability of
these organizations to participate in drug policy is that they are often not considered “legitimate
actors” in the policy space, due to the frequently illicit nature of drug production, sale, and use,
as well as the reality of social stigma. PWUD are often not looked at as experts in the policy
field. Organizations led by PWUD can also be vulnerable and unstable on account of the limited
number of potential members, the limited personal resources available to many PWUD which
reduce their capacity to perform institutional work, and the fact that PWUD often undergo
9

Jürgens, Ralf Erich. "Nothing about Us without Us": Greater, Meaningful Involvement of People Who Use Illegal
Drugs: A Public Health, Ethical, and Human Rights Imperative. Toronto, Ontario, Canada: Canadian HIV/AIDS
Legal Network, 2008.
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periods of incarceration. That being said, some organizations, such as the Danish Drug Users’
Union, have survived the worst of these challenges, continuing to operate through their
president’s two year imprisonment. Organizations of PWUD need resources to be stable, and
may achieve this through ties to other social services or NGO’s, or even the receipt of public
funding.10 One organization of PWUD important to this research due to their UN-level advocacy
is the International Network of People Who Use Drugs and associated regional networks
including the Eurasion Network of People who Use Drugs, the European Network of People who
Use Drugs, the Latin American Network of People who Use Drugs, the Middle East and North
African Network of People who Use Drugs, the Network of Asian People who Use Drugs, and
the International Network of Women who Use Drugs.

INPUD and associated networks
The International Network of People Who Use Drugs (INPUD) was established through
the Vancouver Declaration in 2006. The Vancouver Declaration, established at the International
Harm Reduction Conference in April of 2006, sets out demands and promotes the establishment
of an international network of activists who use drugs. The declaration highlights the history of
marginalization and discrimination against people who use drugs and promotes the right to
self-representation and empowerment. The organization now known as INPUD was tasked with
promoting a better understanding of the experience of people who use drugs, advocating for
universal access to harm reduction tools, promoting PWUD’s rights to educate peers and fellow
citizens, establishing a right to evidence-based information about drugs, supporting other
established networks of people living with HIV/AIDS, Hepatitis, and harm reduction groups, and
10

Frank, Anker, J., & Tammi, T. (2012). Drug User Organizations in the Nordic Countries-Local, National, and
International Dimensions.” Substance Use & Misuse, 47(5), 462–473.
https://doi.org/10.3109/10826084.2012.644095
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challenging “the national legislation and international conventions that currently disable most of
us (PWUD) from living safe, secure and healthy lives.”11 INPUD was seen as a path to liberation
through the active involvement of PWUD. INPUD considers itself “a global peer-based
organization that seeks to promote the health and defend the rights of people who use drugs.”12
Regional networks, and the International Network of Women Who Use Drugs are members of
the INPUD which focus on regional issues and contribute to INPUD’s international advocacy. In
INPUD’s Strategic Plan from 2021-2024, one of their four strategic directions is advocacy and
campaigning at a global, regional, and national level.13 INPUD represents people who use drugs
at the UN and with international development agencies, such as the Global Fund.14

Participation of PWUD at the UN
UN agencies have acknowledged the importance of participation by people who use
drugs in the creation of policy. In the Outcome Document from the 2016 United Nations General
Assembly Special Session, they “note that affected populations and representatives of civil
society entities, where appropriate, should be enabled to play a participatory role in the
formulation, implementation, and the providing of relevant scientific evidence in support of, as
appropriate, the evaluation of drug control policies and programs.”15 The UN Chief Executives
Board in 2019 committed to “promote the active involvement and participation of civil society
and local communities, including people who use drugs” in their activities as well.16 However,
11

The International Activists Who Use Drugs. "The Vancouver Declaration." April 30, 2006.
https://www.inpud.net/en/vancouver-declaration.
12
INPUD. "Our Aims." INPUD. Accessed December 10, 2021. https://www.inpud.net/en/our-aims.
13
Baer, James. "Strategic Plan 2021-2024," INPUD Secretariat. April 2021.
https://www.inpud.net/sites/default/files/INPUD%20Strategic%20Plan%202021-2024.pdf
14
INPUD. “What We Do.” INPUD. Accessed December 10, 2021. https://www.inpud.net/en/what-we-do.
15
UN 2016. UN, Outcome Document of the 2016 United Nations General Assembly Special Session on the World
Drug Problem New York, 19-21 April 2016: Our joint commitment to effectively addressing and countering the
world drug problem (2016) http://www.unodc.org/documents/postungass2016//outcome/V1603301-E.pdf
16
UN 2019. UN, Chief Executives Board for Coordination - Summary of Deliberations [Press release]
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the literature that actually exists on the participation of people who use drugs in UN
policy-making has been largely mixed.
“Making legitimacy: Drug user representation in United Nations drug policy settings”
critically examines how “drug user representation” has operated in the UN Commission on
Narcotic Drugs (CND) over the last thirty years by critically examining nine policy processes
between 1987 and 2019 in which there was evidence of drug user representation. Reviews of
formal and informal documentation, interviews, and records of what was said led researchers to
conclude that UN processes delimit the role of people who use drugs through the mechanisms for
representation and types of spaces made available. In terms of mechanisms, representatives can
only participate in UN/CND meetings as members of state delegations or via NGOs with UN
Economic and Social Council (ECOSOC) Consultative Status. ECOSOC consultative status can
constrain drug user representation because NGO’s need “official government recognition” to
gain this status, and peer-based drug user organizations often cannot obtain this status due to the
criminalization of drug use. Often, representatives of peer-led drug user networks enter under the
banner of other NGO’s, but this obscures the knowledge and expertise of PWUD and the role
they play, while also subjecting them to some degree of control by other NGO’s. Throughout the
nine processes analized, four individuals identified as representing PWUD were part of UN
member delegations. In addition, this paper highlights that representatives of PWUD are often
only invited to speak at “side events,” which also places limitations on the role of PWUD’s
expertise. Finally, this paper highlights that narratives that accept criminalization, stigmatization,
and medicalization dominate much of UN discourse. PWUD are often asked only to offer
“personal narratives” and are not considered policy experts. Researchers highlight “human rights
(2019) Retrieved from https://www.unsceb.org/CEBPublicFiles/CEB-2018-2-SoD.pdf
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discourses” as a way PWUD resist the dominant narratives and delegitimatization of the
expertise of PWUD.17 This paper accomplishes a comprehensive analysis of the participation of
PWUD in this UN context and establishes a base for further research in this field. However it
does not cover many aspects of the UN advocacy of PWUD, including how organizations of
PWUD engage with various UN agencies “behind the scenes.”
Due to the limitations of formal academic research, one must turn to the publications
organizations of PWUD produce about their own work. While INPUD’s descriptions of its own
role in international policy may be prone to bias and self-promotion, they provide valuable
information about INPUD’s ongoing work. In January 2018, INPUD was asked to provide input
into a draft of the ‘International Standards on Drug Use Disorders’ in its final stages. A case
study published by INPUD highlights how INPUD found problems with statements in this draft
and published an open letter which was signed by 188 civil society organizations, which resulted
in the postponement of the release of the standards and an opportunity for an INPUD working
group to contribute to a revision of the draft.18 INPUD also engages with the Global Fund,
providing technical assistance, receiving grants and advocating for rights-based approaches,19
consults with UNAIDS, and publishes responses letters and responses designed to put pressure
on UN bodies at various points in policy-making processes.20

17

Madden, Annie, Kari Lancaster, Alison Ritter, and Carla Treloar. “Making Legitimacy: Drug User Representation
in United Nations Drug Policy Settings.” The International journal of drug policy 87 (2021): 103014–103014.
18
Agliata, Jake. "Case Study: Drug User Advocates Mobilise around WHO/UNODC International Treatment
Standards on Drug Use Disorders." INPUD Secretariat Unit, 26 April, 2021.
https://www.inpud.net/sites/default/files/INTL%20Treatment%20Standards%20Case%20Study.pdf
19
France, Ferris and Mick Matthews. "From Invisibility to Influence: The evolution of participation of people who
use drugs in the Global Fund." INPUD Secretariat Unit. 2021.
https://www.inpud.net/sites/default/files/From%20Invisibility%20to%20Influence_v3%20%281%29.pdf
20
INPUD “Joint Response to the UNAIDS Strategy Team on the Global AIDS Strategy 2021-2026.”
https://www.inpud.net/en/joint-response-unaids-strategy-tream-global-aids-strategy-2021-2026
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Results and Analysis
Getting “a foot in the door” - Challenges to accessing UN spaces
One common theme throughout research interviews is that access to opportunities for
participation is a complicated process for any civil society organization, but especially for groups
composed of PWUD.
First, there are a set of challenges described in the interviews which make it difficult for
organizations led by PWUD to flourish and reach the point at which they may be invited to the
UN. Judy Chang, executive director of INPUD, highlighted that, while INPUD started in 2006 it
took an additional ten years for the organization to reach a point at which it managed its own
finances, largely due to the legal complications of being an international drug user-led network in
a world where many nations continue to criminalize many aspects of drug production and use. In
fact, because “drugs” is featured prominently in the name of the organization, INPUD has yet to
open an official bank account.
Finances are also a serious challenge for organizations of PWUD, as proposed in
previous research on organizations of PWUD in Nordic countries.21 Both Judy Chang of INPUD
and Frank Crichlow, President of the board of the Canadian Association of People Who Use
Drugs (CAPUD) and Chair of the Toronto Drug Users Union, lamented the fact that the amount
of work they want to do outstrips significantly the funding that they have. Crichlow highlighted
how CAPUD is the biggest organization of PWUD in Canada, and they are involved in almost
every other organization and are looked at as the “main” drug users group, but they don’t always
have the funding to allow them to serve the role which has been laid out for CAPUD. In addition,
Judy Chang highlighted that receiving government funding altered and focused the way that

21

Frank, Anker, J., & Tammi, T. (2012). “Drug User Organizations in the Nordic Countries-Local, National, and
International Dimensions.” 462–473.
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INPUD operates, while Frank Crichlow pointed to the funding that CAPUD receives from the
Canadian Ministry of Health as key to the organization's operation: in fact, CAPUD consults
regularly with Health Canada.
In addition to the large-scale challenges associated with being an organization led by
people who use drugs in the international arena, there are many barriers to participation created
by the UN itself and accepted, generally, as “the way things are.” Judy Chang described the
processes of accessing UN spaces as “lengthy” and “bureaucratic.” Some of INPUD’s active
work is in trying to understand these miscellaneous processes and determine which of them are
the most valuable. In other words, INPUD actively works to understand which bureaucratic
barriers to participation are worth understanding and overcoming, especially because INPUD is
comparatively underresourced as a global NGO.
One bureaucratic process which blocks the meaningful participation of PWUD in events
by the Commission on Narcotic Drugs, a process already examined in the literature,22 is
ECOSOC status. ECOSOC Consultative status is required to be one of the civil society groups
consulting in this key UN space, but according to Judy Chang “There isn’t one drug-user led
network that has been accepted and accredited.” Applications for ECOSOC Consultative status
are only open every two years, and the review time is typically one year. Chang speculates that
INPUD’s ECOSOC application is being blocked by the Russian government. Their application
has been held as they receive questions Chang considers “arbitrary” from ECOSOC and suffer
long reponse times. “We are seeing a lot of pushback against organizations working on human
rights and any organizations with drugs in the name,” Chang claimed, “especially those led by

22

Madden, Annie et al. “Making Legitimacy: Drug User Representation in United Nations Drug Policy Settings.”
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people who use drugs.” In the case of ECOSOC, a seemingly neutral regulatory body ultimately
forms a major stumbling block on the path to full participation of PWUD.
The Vienna NGO Committee on drugs represents an opportunity and a challenge for
organizations of PWUD as well. INPUD is a member of the Vienna NGO Committee on drugs, a
committee designed to facilitate civil society’s involvement with Vienna-based UN offices
including the Commission on Narcotic Drugs, the United Nations Office on Drugs and Crime,
and the International Narcotics Control Board. While their website highlights the Vienna
Committee’s role as it aims to “promote collaboration,” “enhance communication,” and “ensure
balanced representation,”23 Chang highlighted that they also play a role as gatekeepers. The
Vienna Committee has control over which organizations are included at CND events and how,
and the Vienna Committee is responsible for connecting civil society organizations with UN
agencies generally. In a global culture that stigmatizes, discriminates against, and generally
devalues PWUD, at an organization immersed in dominant discourses of medicalization and
criminalization, it is not hard to imagine that organizations led by PWUD may have difficulty
passing through the gate the Vienna Committee keeps.
Often, as a work-around to the challenges of ECOSOC status, organizations of PWUD
may participate in side events under the banner of other organizations. As an anonymous
representative of a youth organization stated, getting access to CND is “not that hard.” ECOSOC
members can organize and submit side events, and they are permitted “10 passes each, so even
non-ecosoc members can attend the CND on an ECOSOC members pass.” This, however, can
come with a set of challenges to full participation. First, organizations led by PWUD are
somewhat “at the mercy” of other civil society organizations. Second, even if organizations led
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by PWUD get the chance to contribute their knowledge, this knowledge is obscured, and PWUD
do not get credited for their expertise. Third, Judy Chang highlighted that PWUD are often
considered sources of “personal narrative” and not allowed or encouraged to contribute policy
expertise. “Many people won’t value our voices,” Chang stated, “and then people who say they
do just want you to give personal testimony. They want to organize and brand their events and
then pull in a token PWUD to share their ‘life story.’” INPUD wants PWUD recognized as
policy experts. While Crichlow highlighted “lived and living experience,” experience that he
says comes at a “high cost,” as the key reason that the knowledges of PWUD are necessary and
must be promoted, both Chang and Crichlow emphasized that PWUD need to be involved in all
aspects of policy-making, and should not be framed as tokenized story-tellers, used to emphasize
another NGO’s mission. At present, organizations of PWUD are often subject to the will of
organizations not explicitly led by PWUD at the CND.

How organizations led by PWUD participate
Through national and international organizing, organizations of PWUD have gained
access to a number of UN agencies, and engage in participation and advocacy at multiple levels.
Because “Making Legitimacy” already covers the nature of the “side events” and does extensive
analysis of the participation of PWUD at CND conferences, this research will focus much of its
attention elsewhere. Analysis of interviews revealed that organizations of PWUD have a greater
ability to participate in certain UN bodies, subcomittees, and aspects of work than in others, a
subject worthy of review. In addition, this research will focus on three case studies of
participation –– CAPUD’s involvement in the Canadian delegation to the CND, the development
of the International Standards for the Treatment of Drug Use Disorders, and the

18
not-yet-published World Health Organization Consolidated Guidelines on HIV, Hepatitis and
STIs services.

Comparative Spaces
The executive director of INPUD had a lot to say about which spaces INPUD is
welcomed to participate in meaningfully and which spaces they still struggle to access. One of
the key factors that Judy Chang highlighted is that, across the board, INPUD is much more likely
to be invited to consult with teams focused on HIV/AIDS than they are to be involved in other
areas of the UN’s drug policy. She credited this fact to the long history of human rights-based
HIV/AIDS activism stretching back to the 1970’s. Activists who fought to end stigma and
discrimination, improve treatment, increase international attention and funding, and generally
defend the rights of people living with HIV/AIDS and members of vulnerable populations also
opened out spaces for members of vulnerable populations to participate in policy-making. This
history may make those who work in and study HIV more likely to engage with people who use
drugs, as people who inject drugs have long been one of the key populations, and the spaces
where work is done often have long-established collaborations with community organizing by
PWUD. In fact HIV/AIDS scholarship and harm reduction scholarship are and always have been
closely linked. Thus INPUD engages in close collaboration and consultation with UN staff
working in HIV. INPUD is a member of the strategic advisory group to the UN on HIV and drug
use. INPUD operates as a key advisor to the Global Fund and receives grants from the Fund.
INPUD also engages in ongoing collaboration with UNAIDS. Other than, essentially, showing
up and doing side events at annual CND meetings, INPUD gains access to UN spaces not strictly
focused on HIV and meets with other colleagues primarily because the organization is “brought
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in” by HIV/AIDS-connected staff. The fundamental problem with accessing some spaces, like
the UN Office of Drugs and Crime, is that compared to health spaces, these UN bodies take an
inherently punitive approach to drugs and drug use, as the name of this office clearly
demonstrates. In these spaces, people are less likely to collaborate with PWUD or consider them
to be experts.
In fact, a representative of a youth organization which participates in CND conferences
described the CND, which functions as the governing body of the UNODC, as “the place where
dreams go to die,” with a “banality of evil” aspect to it. According to this representative, “any
positive reform is fought over the terrain of minor language changes, and resolutions largely do
not have huge impacts.” They presented the 2020 attempt to reschedule cannabis which was
blocked by Russia on the grounds that the CND was “too incompetent” to reschedule cannabis,
despite the fact that CND scheduled many other drugs that year, as an example of this failure.
While they acknowledge that there have been productive international discussions, that human
rights are in the process of coming into focus, and that the “punitive consensus” of the CND has
at last been broken, this representative remained pessimistic about the UN, and the CND
specifically, ever operating as a space for true reform where the voices of PWUD are heard.

The Canadian Delegation
There is one notable exception to the general voicelessness of PWUD in these broad drug
policy making spaces: as mentioned in “Making Legitimacy” PWUD can participate in CND
conferences either through the organization of side events or as members of a national
delegation. However, according to Frank Crichlow, only one country has chosen to include
representatives of organizations of PWUD as members of their delegation –– his home country
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of Canada. For multiple years, Canada brought the president and the executive director of
CAPUD as members of the country’s CND delegation. Crichlow’s experience as a representative
in the main hall of the CND delegation shows a unique way that PWUD have participated in UN
policy and provides insights into the ongoing obstacles for ongoing meaningful participation.
The first year that Crichlow and the executive director of CAPUD had the opportunity to
speak at the CND they advocated primarily for changes in the rules of the CND’s operations and
for the greater participation of PWUD in the CND space, aiming to create a voice. While there,
Crichlow was invited to do a side table with the Minister of Health from Sweden. The Canadian
and Swedish delegations sat together in private and Crichlow lended his knowledge about the
experience of opening a supervised consumption site, primarily answering questions about his
experience opening and operating such sites in Canada. The same year Crichlow met with the
minister from Portugal to discuss Crichlow’s views on the legalization of cannabis in Canada.
Crichlow highlighted his opinions that all drugs should be legalized, not just this one, and
pointed out the injustice of cannabis in Canada becoming a “money making business” for “the
same people who were incarcerating” others for cannabis-related legal infractions, especially
black people, indigenous people, and people of color, many of whom were still incarcerated or
still had a legal record.
The following year Crichlow returned to the CND as a member of the Canadian
delegation and presented on race, stigma and discrimination and the impacts thereof on the black
community. He claimed the safe supply program in Canada was racist and designed to benefit
white people and not BIPOC. This claim was based on the fact that the safe supply program was
designed to protect people who inject drugs, a form of drug use more widely represented in white
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populations, even as the program did nothing to protect people who smoke crack, a form of drug
use more widely represented among BIPOC.
CAPUD’s opportunity to present in the main hall at the CND and participate as a member
of a country delegation is unique. Crichlow pointed out that in addition to Canada being on a
path to drug decriminalization, providing needle exchanges without limitations, having 24/7
harm reduction services and delivery services, Canada is also the only nation to send PWUD,
people with “living and lived experience” to the United Nations. An analysis of Crichlow’s
statments and forms of participation shows that PWUD can bring a unique and important
combination of knowledges to UN policy fora. CAPUD participated both in private and public
sessions and brought three broad categories of knowledge: expertise in service provision for
PWUD, evidence-based policy recommendations, and policy perspective designed to emphasize
the voices of marginalized populations and promote social justice. Crichlow’s participation
shows what role PWUD can and already do play when PWUD successfully access opportunity
for participation.
Crichlow also made a number of observations when interviewed that highlight how far
the CND still has to go to promote meaningful participation by PWUD. He emphasized that at
the CND the CAPUD representatives only were two people with lived and living experience
among thirty-two, the other thirty of whom were trained as doctors and psychiatrists. “Because
they have the acronyms behind their names,” Crichlow stated, “they believe they are better than
us.” He emphasized a need to have everyone “at the table,” not just a token person who uses
drugs: “I’m talking sex workers, LGBTQ people, black and indigenous and people of color.
Everyone should be on the panel.” In short, Crichlow highlighted two issues: the first is the
minimal representation of people who use drugs in spaces designed to create policy pertaining
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largely to people who use drugs. This lack of representation is both undemocratic and
impractical, because it denies PWUD ownership over the policy that affects them and cuts out
one of the best sources for knowledge and experience available. Crichlow pointed out that one
person isn’t enough, nor is two, because there are a variety of experiences, all of which need to
be captured and understood. The second is the delegitimization of the knowledge of PWUD and
cultural understandings of expertise. While representatives of CAPUD were present, Crichlow
didn’t necessarily feel like he was being regarded as an expert in a room full of academics and
doctors. “However much you’re paying for your school,” Crichlow told me, “my expertise cost
me more ––– drugs are expensive.” This differential way of valuing certain forms of knowledge
is present in and out of the UN, and its construction delimits the role of PWUD in
policy-making.

The International Treatment Standards
Close to what was meant to be its final stage, the WHO/UNODC International Standards
for the Treatment of Drug Use Disorders came across the desk of the Executive Director of the
International Network of People Who Use Drugs. Typically when INPUD consults on UN
documents, they are commissioned and participate in the review process at all stages. This was
not the case when it came to the International Treatment Standards, which were approaching
field testing stages. Chang described what she found in the document as “very awful.” Chang’s
primary issue with the Treatment Standards at that stage was that it leaned very heavily on the
“brain disease model” of addiction, a model deemed by INPUD to be stigmatizing and
pathologizing. In addition, INPUD objected to the lack of meaningful inclusion of PWUD in the
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development of The Standards and the failure of the Standards to mention harm reduction and
other important health measures for PWUD.24
INPUD responded in two ways simultaneously: they submitted ten pages of line-by-line
input on the document as written and published an open letter which detailed three main
objections to The Standards. The open letter was signed by 188 community and civil society
organizations. As part of the strategic advisory group to the UN INPUD also published another
letter to the executive director. By Chang’s report, high level UN officials were upset about the
letter, and the situation reached the office of WHO Director-General Tedros Adhanom, who was
“quite embarrassed about what happened.” Quickly, INPUD heard back that the Treatment
Standards were going to be completely rewritten. INPUD was invited to meet with two
department heads, one from WHO and the other from UNODC. INPUD had a small meeting in
exchange during which they shared their concerned. Ultimately, an entirely new consultant was
hired to rewrite the standards and INPUD was in constant dialogue with the writers throughout
the revision process. During the field testing stage, three countries worked with INPUD contacts
allowing there to be “more detailed inputs” to the field testing portion. INPUD was invited to
speak at a side event when the International Treatment Standards with field testing were
launched. A member of the South African Network of People who Use Drugs attended.
Judy Chang described The Standards as they currently exist as an “imperfect but better
document” than the original. This case study demonstrates how organizations of PWUD use
different tools in order to participate fully in the creation of UN-level drug policy. First, INPUD
has gained sufficient expertise to be considered an international expert, so they are consulted on
WHO/UNODC publications. In this particular case, the obstacle to participation which INPUD
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overcame was the fact that they were only included in final-stages review of the initial document,
instead of being welcomed throughout the process. In order to resist and advocate for greater
participation, the organization made a public appeal in the form of an open letter. This allowed
for widespread mobilization of PWUD and called public attention to the issue, prompting UN
bodies to respond. Having largely succeeded in their public appeal, INPUD then provided
behind-the-scenes expertise, actively participating in the development of what would become the
International Treatment Standards. Because INPUD is a global network, they were able to
participate in and exercise some control over the field-testing stage. Throughout the process, they
also gained more contacts and ways of participating in the WHO/UNODC.
In the interview, Chang emphasized that INPUD does not take the decision to “go public”
lightly. Making public appeals such as the open letter risks offending and embarrassing key
contacts INPUD has within the UN and hurting their ability to consult in the future. INPUD
largely prefers to push back and create change as documents are developed, accepting a certain
degree of give and take. “Once you’re at the table you have to use tactics,” Chang stated, “our
role is to negotiate and collaborate with UN agencies while holding them accountable.” “You can
call people out and draw attention, but other times it’s more collaborative and discussion-based.”
She emphasized the necessity of reading the political environment. They hope to improve
policies, even though they may not get every change they would like throughout the
development process. The development of The Standards demonstrates how organization by
PWUD can allow PWUD to both resist UN action and collaborate with the UN to create policies
more in line with the will of PWUD.

WHO Key Populations' Values and preferences for HIV, Hepatitis and STIs services
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INPUD is involved in an ongoing process of creating consolidated guidelines for key
populations with the World Health Organization. The guidelines are for HIV/AIDS, Hepatitis
and STI services. Instead of meeting with department heads, as they did after demanding a
rewrite of the International Standards for the Treatment of Drug Use Disorders, INPUD has
regular meetings directly with internal technical specialists involved in the production of the
consolidated guidelines. INPUD produces their own work and receives commission for research
which they send in to the team creating the guidelines.
This process is considered to be more in line with the INPUD’s usual form of
involvement with the creation of UN policy and publications. By positioning themselves as
experts with research capacity and access to groups of PWUD throughout the world, INPUD has
gained the ability to participate and interact with UN bodies. “We’ve built relationships and
proved ourselves to be a valuable partner,” Chang stated. INPUD highly values the relationships
that they form with technical specialists within the UN, because they form a path to further
participation and greater political power. The internal technical specialists INPUD works with
become touchpoints when INPUD has concerns about what is happening globally. “If there’s an
issue with a stockout in Lebanon, we’ll be in contact with those people,” Chang stated, “when
there are changes to harm reduction programs in Vietnam, we’ll reach out.” INPUD leverages the
contacts they form on a global level to change regulations at the national level, even in small
ways.
INPUD leverages their role as experts to contribute to the development of international
policy guidelines, but they also gain and develop relationships with contacts in the process.
Relationships with individuals are a key way INPUD finds a way to access opportunities for
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participation internationally, nationally, and locally. “Networking” becomes a key element of
ongoing advocacy and participation.

Opinions of Organizations: what is necessary for improved participation
Both Frank Crichlow and Judy Chang emphasized the necessity of two elements to
produce meaningful participation of people who use drugs in UN fora. One is involvement of
diverse groups of people who use drugs: INPUD set up its regional structure to reduce the hold
that the Global North had over the organization. The board of CAPUD comes from every region
of Canada. Organizations of PWUD resist the tokenization of PWUD and emphasize the
perceived need for a plurality of representatives whose knowledges are legitimized. Frank
Crichlow especially emphasized the stance that PWUD who are also members of marginalized
communities, such as LGBT people, sex workers, and BIPOC, need to be at the table
participating in decision making.
Conceptualizing this as an obstacle to participation, one can say that currently the
existing policy fora at the UN do not offer sufficient opportunity for participation of high
numbers of PWUD. While individual executives at INPUD can work behind the scenes with the
UN, and occasionally representatives of PWUD appear at the CND main hall or side events,
there simply isn’t sufficient space for the continuous participation of multiple PWUD. PWUD
are continuously tokenized and are numerically underrepresented, making it especially difficult
for minority communities to be represented.
Chang also emphasized the need for PWUD to be involved “in the beginning of every
long term process,” leaving PWUD “less in the dark” about what is happening in the world of
relevant policy development, reducing confusion and making it easier for people who use drugs
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throughout the policy-making process. The two INPUD case studies of The Standards and the
Key Population guidelines highlight how the experience of participation differs greatly when
PWUD are involved early, in contrast to only being involved in a last-minute review. Crichlow
echoed this sentiment, stating that “people who use drugs should be involved from the beginning
to the end, in every facet of life.” A failure to continuously and systematically include the
perspectives of PWUD poses a serious obstacle to the true and meaningful participation of
people who use drugs in policy making.
Overall, PWUD remain broadly underrepresented in spaces where the UN makes policy
pertaining to PWUD. This is true despite the fact that PWUD are and always have been central to
harm reduction and other effective health efforts in their communities. In addition, a combination
of factors, including the tendency for representatives of organizations of PWUD to need to
contribute under the umbrella of other organizations, has resulted in PWUD going uncredited.
Organizations led by PWUD are currently permitted only limited roles in policy-making: They
are often consulted too late for meaningful participation, as highlighted through the events
surrounding the International Standards for the Treatment of Drug Use Disorders. In addition,
PWUD are only granted to certain roles and spaces. They may be involved through UN contacts,
through the application of public pressure, or because the gatekeepers to conferences and
policy-making spaces let them through, but the participation of PWUD in policy making is by no
means comprehensively integrated into policy-making procedure. In addition, PWUD are
somewhat confined in the narratives they can convey in the policy-making spaces due to
dominant discourses and the way that power is allocated within the UN. Stigma, discrimination
and criminalization limit the participation of PWUD in policy-making at every level.
Bureaucratic hurdles such as acquiring ECOSOC consultative status play a role in limiting the
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participation of PWUD in policy-making, as do limitations in financing. Organizations of PWUD
consider community mobilization to be an important path to accessing a greater role in
policy-making. PWUD are able to contribute a unique combination of knowledge and experience
to policy-making spaces. Organizations of PWUD use a variety of strategies to make their voices
heard despite obstacles. Some examples of the strategies described include the leveraging of
contacts within the UN, the application of pressure through public appeals, developing research
capacity which makes organizations of PWUD a valuable UN partner, engaging in private
consultations with various health authorities, and showing up to conferences and events and
speaking out about issues.

Conclusion
The aim of this research was to fill a gap in the academic literature and elucidate the
current modes of participation of PWUD in drug-related policy-making at the United Nation. In
place of merely identifying the current barriers to involvement, this research was organized
around the idea of “meaningful participation” and aimed to both acknowledge obstacles and
highlight the work that organizations of PWUD are already doing at the UN.
While organizations of PWUD have developed significant inroads which grant said
organizations access to many aspects of policy-making and recommendation-development, there
is no comprehensive system for the participation of PWUD on policy-making at the UN. This is
true despite the UN’s purported belief that participation, including participation of PWUD, is a
“main requirement of policy-making.” Instead, organizations of PWUD jump through hoops to
gain access and prove themselves valuable to the UN. Organizations of PWUD do use the
strategies available to them to make changes within the UN system. They are engaged constantly
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in attempts to contribute as much as possible to the policy which impacts the lives of PWUD.
This sometimes involves negotiation and tactical compromise. Organizations of PWUD decide
whether to represent themselves under the banner of other organizations, and whether to
publicize criticisms or preserve certain valuable partnerships. Continued participation is anything
but guaranteed and freedom of expression is limited in multiple ways. However, overall patterns
show that PWUD are gaining more access to meaningful participation over time.
Several limitations ultimately impacted this research. First, while the research aimed to
fill a literature gap, this gap also created challenges in gathering all the necessary information. In
addition, the research was time-constrained which limited the number of participants. Many
conclusions rely heavily on the perspectives of two people from connected organizations. In
addition, because some private correspondences and meetings were discussed, certain elements
of the research used as evidence cannot be confirmed. Thus this paper is in part a work of trust.
With additional time, this research may have covered more comprehensively the participation of
PWUD throughout the United Nations as well. Continuing research is necessary to model the full
participation of PWUD in UN-level policy-making and shape a comprehensive theory of this
process. In addition, there is potential for research on UN-level drugs policy-making to place this
process within comprehensive frames of power, racial capitalism, neoliberalism and
neocolonialism.
There are practical responses to the limitations still placed on the meaningful
participation of PWUD in UN-level policy-making. UN bodies might begin to build up systems
for inclusion and reform gatekeeping mechanisms such as ECOSOC. As nations like Canada
move towards decriminalization national delegations may begin to play a role in promoting
inclusion as well. However, the current lack of meaningful participation of PWUD in many areas
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is directly tied into globally dominant forces and discourses. Medicalization denies PWUD
agency and choice, framing PWUD only as "diseased" and therefore weakening their voices as
experts while elevating medical expertise which is also biased by biomedical structures.
Criminalization, perpetuated by the UNODC, produces significant challenges for the
organization and mobilization of groups of PWUD which is a precursor for participation and
liberation. It creates legal hurdles and justifications for non-inclusion. Broad cultures of
stigmatization delegitimize the voices of PWUD as well. The UN is not only subject to these
forces –– it is fully entrenched in them –– and only a deliberate, critical engagement with this
reality can move the UN towards fuller participation by PWUD. PWUD are already pushing the
United Nations in this direction and opening up more spaces for their voices to be heard.
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INPUD - International Network of People who Use Drugs
LGBTQ - Lesbian, Gay, Bisexual, Transgender, Queer or Questioning
NGO - Non-governmental Organization
PWUD - People Who Use Drugs
UN - United Nations
UNAIDS - Joint United Nations Programme on HIV/AIDS
UNODC - United Nations Office on Drugs and Crime
WHO - World Health Organization

32
Bibliography
Agliata, Jake. "Case Study: Drug User Advocates Mobilise around WHO/UNODC International
Treatment Standards on Drug Use Disorders." INPUD Secretariat Unit, 26 April, 2021.
https://www.inpud.net/sites/default/files/INTL%20Treatment%20Standards%20Case%20
Study.pdf
Baer, James. "Strategic Plan 2021-2024," INPUD Secretariat. April 2021.
https://www.inpud.net/sites/default/files/INPUD%20Strategic%20Plan%202021-2024.pd
f
Bathje, Geoff Daniel Pillersdorf, & Steve Du Bois. (2019). “Authoritarianism, attitudes toward
harm reduction and the stigmatisation of people who use drugs.” Alkoholizm i
Narkomania, 32(2), 77–86. https://doi.org/10.5114/ain.2019.87624
Broyles, Lauren M., Ingrid A. Binswanger, Jennifer A. Jenkins, Deborah S. Finnell, Babalola
Faseru, Alan Cavaiola, Marianne Pugatch, and Adam J. Gordon. "Confronting
Inadvertent Stigma and Pejorative Language in Addiction Scholarship: A Recognition
and Response." Substance Abuse 35, no. 3 (07, 2014): 217-221.
doi:http://dx.doi.org/10.1080/08897077.2014.930372.
Chang, Judy. Interview by Lily Knudsen. Personal Interview. December 3, 2021.
Chang, Judy, Shaun Shelly, Machteld Busz, Claudia Stoicescu, Rachman Iryawan Arif, Dinara
Madybaeva, Yuri de Boer, and Andy Guise. "Peer Driven Or Driven Peers? A Rapid
Review of Peer Involvement of People Who use Drugs in HIV and Harm Reduction
Services in Low- and Middle-Income Countries." Harm Reduction Journal 18, (2021):
1-13. doi:http://dx.doi.org/10.1186/s12954-021-00461-z.
Crawford M J, Rutter D, Manley C, Weaver T, Bhui K, Fulop N et al. “Systematic review of

33
involving patients in the planning and development of health care.” BMJ 2002; 325 :1263
doi:10.1136/bmj.325.7375.1263
Crichlow, Frank. Interview by Lily Knudsen. Personal Interview. December 10, 2021.
de Freitas, Cláudia and Graham Martin. "Inclusive Public Participation in Health: Policy,
Practice and Theoretical Contributions to Promote the Involvement of Marginalised
Groups in Healthcare." Social Science & Medicine 135, (06, 2015): 31-39.
doi:http://dx.doi.org/10.1016/j.socscimed.2015.04.019.
Faulkner-Gurstein, Rachel. (2017). “The social logic of naloxone: Peer administration, harm
reduction, and the transformation of social policy.” Social Science & Medicine. 180.
10.1016/j.socscimed.2017.03.013.
France, Ferris and Mick Matthews. "From Invisibility to Influence: The evolution of
participation of people who use drugs in the Global Fund." INPUD Secretariat Unit.
2021.
https://www.inpud.net/sites/default/files/From%20Invisibility%20to%20Influence_v3%2
0%281%29.pdf
Frank, Anker, J., & Tammi, T. (2012). Drug User Organizations in the Nordic Countries-Local,
National, and International Dimensions.” Substance Use & Misuse, 47(5), 462–473.
https://doi.org/10.3109/10826084.2012.644095
Frankish, James C, Brenda Kwan, Pamela A Ratner, Joan Wharf Higgins, Craig Larsen,
“Challenges of citizen participation in regional health authorities,” Social Science &
Medicine, Volume 54, Issue 10, 2002, Pages 1471-1480, ISSN 0277-9536,
https://doi.org/10.1016/S0277-9536(01)00135-6.
Global Commission on Drug Policy. “The world drug perception problem-countering prejudices

34
about people who use drugs: 2017 report.” Jan 2018.
www.globalcommissionondrugs.org/wp-content/uploads/2018/01/GCDP-Report-2017_P
erceptions-ENGLISH.pdf.
INPUD “Joint Response to the UNAIDS Strategy Team on the Global AIDS Strategy
2021-2026.”
https://www.inpud.net/en/joint-response-unaids-strategy-tream-global-aids-strategy-2021
-2026
INPUD. "Our Aims." INPUD. Accessed December 10, 2021. https://www.inpud.net/en/our-aims.
INPUD. “What We Do.” INPUD. Accessed December 10, 2021.
https://www.inpud.net/en/what-we-do.
International standards for the treatment of drug use disorders: revised edition incorporating
results of field-testing. Geneva: World Health Organization and United Nations Office on
Drugs and Crime; 2020. License: CC BY-NC-SA 3.0IGO.
Jakubowski, Elke, Graham Lister, Regina Skavron, and World Health Organization. "Ninth
Futures Forum on health systems governance and public participation: Amsterdam, The
Netherlands, 10-11 October 2005." (2006).
Jürgens, Ralf Erich. "Nothing about Us without Us": Greater, Meaningful Involvement of People
Who Use Illegal Drugs: A Public Health, Ethical, and Human Rights Imperative.
Toronto, Ontario, Canada: Canadian HIV/AIDS Legal Network, 2008.
Lancaster, Kari, Alison Ritter, and Rosalyn Diprose. “Recasting Participation in Drug Policy.”
Contemporary drug problems 45, no. 4 (2018): 351–365
Madden, Annie, Kari Lancaster, Alison Ritter, and Carla Treloar. “Making Legitimacy: Drug
User Representation in United Nations Drug Policy Settings.” The International journal

35
of drug policy 87 (2021): 103014–103014.
The International Activists Who Use Drugs. "The Vancouver Declaration." April 30, 2006.
https://www.inpud.net/en/vancouver-declaration.
UN 2016. UN, Outcome Document of the 2016 United Nations General Assembly Special
Session on the World Drug Problem New York, 19-21 April 2016: Our joint commitment
to effectively addressing and countering the world drug problem (2016)
http://www.unodc.org/documents/postungass2016//outcome/V1603301-E.pdf
UN 2019. UN, Chief Executives Board for Coordination - Summary of Deliberations [Press
release] (2019) Retrieved from
https://www.unsceb.org/CEBPublicFiles/CEB-2018-2-SoD.pdf
VNGOC Board." Vienna NGO Committee on Narcotic Drugs. Accessed December 15, 2021.
https://vngoc.org/about-the-vngoc/officers-of-the-vngoc/.

